Founder spotlight: Rachel Bartholomew on advancing femtech and women’s health
Femtech startup Hyivy aims to transform women's health by developing therapeutic devices and software solutions for remote monitoring and personalized treatment
Rachel Bartholomew (MBET ’14) is founder and CEO of Hyivy, a femtech startup focused on creating therapeutic and remote monitoring devices for gynecological conditions with the mission to transform women's health care with modern innovations. She is also founder and a lead advisor for Femtech Canada, an advocacy organization for women working in the innovation space.
Bartholomew, a Waterloo alum from the Conrad School of Entrepreneurship and Business, shares her entrepreneurial journey and how her experiences shaped the company.
What’s your elevator pitch for Hyivy?
Hyivy is creating the first remote therapeutic and monitoring device for gynecological conditions that one in three women will face in their lifetime. Our device targets issues such as pelvic floor conditions, various cancers and chronic illnesses. It’s fully remote, so patients can use it at home, and the data is sent through our mobile app to a system that clinicians can access. Think of it like a CPAP machine, but for gynecology.
